Welcome to My Personal Page
Logan is a smiling and happy two-year-old girl from Kentucky. At the end of September 2017, at just 8 months old, Logan’s Mom noticed a nystagmus in her right eye. On October 23, 2017 an MRI revealed that Logan had a tumor in the center of her brain. After surgery for a biopsy was preformed, it was determined that Logan has Pilomyxoid Astrocytoma as well as Diencephalic Syndrome. Logan’s family was told that surgery to remove the tumor would be too risky due to its location – the only option she had was chemo. Logan Started weekly Carboplatin and Vincristine chemo treatments at Cincinnati Children’s Hospital on December 14, 2017. A little over three months after her first chemo treatment another MRI revealed that Logan’s tumor was still growing. That MRI also revealed that there was a “fleck” of a second tumor now growing in a different area of her brain. At that point, her treatment plan was changed to a MEK Inhibitor (Trametinib), which she started on March 29, 2018. Logan’s most recent MRI showed that the MEK Inhibitor is working and that the tumor and the fleck have both shrunk! If her tumor continues to shrink or remain stable, the plan would be to stay on the MEK Inhibitor for two years and then come off the medicine to see how she does.
Logan continues to thrive and live a full and happy life with her parents, brother and fur brother. She is hitting all the milestones that a child her age should hit, other than weight. She is little but she is fierce and makes up the weight difference in sass, personality and smiles.
I am uniting with others to make a difference in the fight against brain tumors. I am passionate about this cause, so I’m taking action. I need your help in this fight. National Brain Tumor Society will not rest until a cure exists - but more needs to be done. Please join in my effort!
National Brain Tumor Society is fiercely committed to finding a cure for brain tumors. They are aggressively driving strategic research and advocating for public policies that meet the critical needs of the brain tumor community. Your support ensures this important work will continue.
If you think this page contains objectionable content, please inform the system administrator.